A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.
Low Confidence ObservationalPrimary source: [Open]
Linked compounds: ara-290
Outcomes summary
Small Phase 2 clinical trial evaluating cibinetide (ARA 290) in diabetic macular edema, reporting no mean improvement in key visual/anatomic endpoints over the study period but suggesting potential signal in some participants, with no serious safety reactions reported in this cohort.
Limitations
Very small sample size; limited control/comparator context; outcomes are exploratory and may be underpowered; industry involvement.
Notes
Primary source: PMID 32674280.